• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

七价肺炎球菌结合疫苗在5岁以下儿童预防肺炎中的有效性:采用世界卫生组织胸部X光片标准化解读的更新分析

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs.

作者信息

Hansen John, Black Steven, Shinefield Henry, Cherian Thomas, Benson Jane, Fireman Bruce, Lewis Edwin, Ray Paula, Lee Janelle

机构信息

Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA.

出版信息

Pediatr Infect Dis J. 2006 Sep;25(9):779-81. doi: 10.1097/01.inf.0000232706.35674.2f.

DOI:10.1097/01.inf.0000232706.35674.2f
PMID:16940833
Abstract

BACKGROUND

A World Health Organization (WHO) working group in 2001 developed a method for standardizing interpretation of chest radiographs in children for epidemiologic purposes. We reevaluated radiographs from the Kaiser Permanente Pneumococcal Efficacy trial using this method.

METHODS

Seven-valent pneumococcal conjugate vaccine was evaluated in a randomized, controlled study including 37,868 infants. Effectiveness against pneumonia was previously evaluated using the original treating radiologist reading. There were 2841 sets of radiographs from this trial and all available radiographs were scanned and read blindly by 2 WHO crosstrained readers (A and B); discordance between the 2 primary readers was resolved through a consensus reading by an adjudicating panel of 2 radiologists.

RESULTS

Of the 2841 radiographs, 2446 were available for scanning and were reviewed using WHO-defined descriptive categories. Two hundred fifty of the 2446 radiographs were read as positive by both readers. An additional 129 were read as positive by reader A only and 142 by reader B only for a total of 521 radiographs that were read as positive by one or both of the reviewers. The concordance rate between the 2 reviewers was 250 of 521 (48%). Of the 271 discordant radiographs, 45 of 129 (34.9%) of reader A and 66 of 142 (46.5%) for reader B were finalized as positive by the adjudicating panel. Overall, 361 radiographs were finalized as positive (12.7%). With these 361 images as the standard, the sensitivity and specificity of reader A were 82% and 97%, respectively, and for reader B, 88% and 97%, respectively. Kappa between the 2 readers was 0.58. Of 25 control radiographs read as positive by both A and B, 80% were also read as positive by the panel and all 25 control negative radiographs were read as negative by the panel. Using original readings by point-of-care radiologists, efficacy against first episode of radiograph confirmed pneumonia was 17.7% (95% confidence interval [CI] = 4.8-28.9%) in intent-to-treat and 20.5% (95% CI = 4.4-34%) in per protocol. Using the WHO method, the efficacy against first episode of radiograph confirmed pneumonia adjusting for age, gender and year of vaccination of 25.5% (95% CI = 6.5-40.7%, P = 0.011) for intent-to-treat and 30.3% (95% CI = 10.7-45.7%, P = 0.0043) for per protocol.

CONCLUSION

Using WHO criteria for reading of radiographs increased point estimates of vaccine efficacy presumably as a result of improved specificity.

摘要

背景

2001年,世界卫生组织(WHO)一个工作组制定了一种方法,用于标准化儿童胸部X光片的解读,以用于流行病学目的。我们使用这种方法重新评估了凯撒医疗集团肺炎球菌疫苗效力试验中的X光片。

方法

在一项随机对照研究中对七价肺炎球菌结合疫苗进行了评估,该研究纳入了37868名婴儿。先前使用最初的主治放射科医生的读片结果评估了疫苗对肺炎的效力。该试验共有2841套X光片,所有可用的X光片都由两名经过WHO交叉培训的阅片者(A和B)进行扫描并盲法阅片;两位主要阅片者之间的分歧通过由两名放射科医生组成的裁决小组进行共识阅片来解决。

结果

在2841张X光片中,有2446张可供扫描,并使用WHO定义的描述性类别进行了复查。2446张X光片中,有250张被两位阅片者都判读为阳性。另有129张仅被阅片者A判读为阳性,142张仅被阅片者B判读为阳性,因此共有521张X光片被一位或两位阅片者判读为阳性。两位阅片者之间的一致率为521张中的250张(48%)。在271张有分歧的X光片中,阅片者A的129张中有45张(34.9%)以及阅片者B的142张中有66张(46.5%)被裁决小组最终判定为阳性。总体而言,361张X光片最终被判定为阳性(12.7%)。以这361张影像作为标准,阅片者A的敏感度和特异度分别为82%和97%,阅片者B的敏感度和特异度分别为88%和97%。两位阅片者之间的kappa值为0.58。在被A和B都判读为阳性的25张对照X光片中,80%也被裁决小组判读为阳性,所有25张对照阴性X光片都被裁决小组判读为阴性。根据即时护理放射科医生的原始读片结果,在意向性治疗中,疫苗对X光片确诊的首次肺炎发作的效力为17.7%(95%置信区间[CI]=4.8 - 28.9%),在符合方案分析中为20.5%(95%CI = 4.4 - 34%)。使用WHO方法,在意向性治疗中,针对X光片确诊的首次肺炎发作,在调整年龄、性别和疫苗接种年份后,效力为25.5%(95%CI = 6.5 - 40.7%,P = 0.011),在符合方案分析中为30.3%(95%CI = 10.7 - 45.7%,P = 0.0043)。

结论

使用WHO的X光片判读标准提高了疫苗效力的点估计值,这可能是由于特异度提高所致。

相似文献

1
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs.七价肺炎球菌结合疫苗在5岁以下儿童预防肺炎中的有效性:采用世界卫生组织胸部X光片标准化解读的更新分析
Pediatr Infect Dis J. 2006 Sep;25(9):779-81. doi: 10.1097/01.inf.0000232706.35674.2f.
2
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.七价肺炎球菌结合疫苗在五岁以下儿童中预防肺炎的有效性。
Pediatr Infect Dis J. 2002 Sep;21(9):810-5. doi: 10.1097/00006454-200209000-00005.
3
Reliability and validity of the World Health Organization reading standards for paediatric chest radiographs used in the field in an impact study of Pneumococcal Conjugate Vaccine in Kilifi, Kenya.在肯尼亚基利菲开展的肺炎球菌结合疫苗影响研究中,对现场使用的儿童胸部 X 射线片世界卫生组织阅读标准进行可靠性和有效性评估。
PLoS One. 2018 Jul 25;13(7):e0200715. doi: 10.1371/journal.pone.0200715. eCollection 2018.
4
Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.肺炎球菌-流感嗜血杆菌蛋白 D 结合疫苗预防儿童肺炎的效果:一项整群随机试验。
Vaccine. 2018 Sep 18;36(39):5891-5901. doi: 10.1016/j.vaccine.2018.08.020. Epub 2018 Aug 23.
5
Preliminary report from the World Health Organisation Chest Radiography in Epidemiological Studies project.世界卫生组织“流行病学研究中的胸部X光摄影”项目的初步报告。
Pediatr Radiol. 2017 Oct;47(11):1399-1404. doi: 10.1007/s00247-017-3834-9. Epub 2017 Sep 21.
6
Radiographic pneumonia in young, highly febrile children with leukocytosis before and after universal conjugate pneumococcal vaccination.在普及肺炎球菌结合疫苗接种前后,年轻、高热且白细胞增多的儿童中的影像学肺炎情况。
Pediatr Emerg Care. 2009 Jan;25(1):1-7. doi: 10.1097/PEC.0b013e318191dab2.
7
Chest radiograph reading panel performance in a Bangladesh pneumococcal vaccine effectiveness study.孟加拉国肺炎球菌疫苗效力研究中的胸部 X 光读片小组表现。
BMJ Open Respir Res. 2019 Apr 15;6(1):e000393. doi: 10.1136/bmjresp-2018-000393. eCollection 2019.
8
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.九价肺炎球菌结合疫苗对冈比亚肺炎和侵袭性肺炎球菌疾病的疗效:随机、双盲、安慰剂对照试验
Lancet. 2005;365(9465):1139-46. doi: 10.1016/S0140-6736(05)71876-6.
9
Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California.七价肺炎球菌结合疫苗的安全性和有效性:来自北加利福尼亚的证据。
Eur J Pediatr. 2002 Dec;161 Suppl 2:S127-31. doi: 10.1007/s00431-002-1064-z. Epub 2002 Nov 9.
10
The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.9价肺炎球菌结合疫苗对感染和未感染艾滋病毒儿童肺炎公共卫生负担的影响。
Clin Infect Dis. 2005 May 15;40(10):1511-8. doi: 10.1086/429828. Epub 2005 Apr 7.

引用本文的文献

1
Cost-effectiveness of a 13-valent pneumococcal conjugate vaccine compared with currently available pneumococcal conjugate vaccines in Indian children.13价肺炎球菌结合疫苗与印度儿童目前可用的肺炎球菌结合疫苗相比的成本效益。
IJID Reg. 2025 Jul 16;16:100707. doi: 10.1016/j.ijregi.2025.100707. eCollection 2025 Sep.
2
PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysis.用于预防墨西哥儿科人群侵袭性肺炎球菌疾病的13价肺炎球菌结合疫苗:一项成本效益分析。 (注:PCV20全称为13价肺炎球菌结合疫苗,英文表述为13-valent pneumococcal conjugate vaccine,在墨西哥儿科人群中主要使用的是PCV13,这里原文可能有误,但按照要求仅翻译给定内容)
Hum Vaccin Immunother. 2025 Dec;21(1):2475594. doi: 10.1080/21645515.2025.2475594. Epub 2025 Apr 3.
3
Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme.荷兰国家儿童免疫规划中向20价肺炎球菌结合疫苗过渡的经济学评估
Infect Dis Ther. 2025 Mar;14(3):527-547. doi: 10.1007/s40121-025-01109-2. Epub 2025 Feb 7.
4
Clinical Implications of the Obstructive Pattern on Chest Radiography in Children Aged 3-59 Months With Severe Lower Respiratory Tract Infections.3至59个月大患有严重下呼吸道感染儿童胸部X线片上阻塞性模式的临床意义
Pediatr Pulmonol. 2025 Jan;60(1):e27458. doi: 10.1002/ppul.27458. Epub 2024 Dec 23.
5
Cost-Effectiveness Analysis of Routine Childhood Immunization with 20-Valent versus 15-Valent Pneumococcal Conjugate Vaccines in Germany.德国20价与15价肺炎球菌结合疫苗用于儿童常规免疫的成本效益分析
Vaccines (Basel). 2024 Sep 12;12(9):1045. doi: 10.3390/vaccines12091045.
6
An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population.对肺炎球菌结合疫苗PCV20与PCV15在瑞典儿科人群中预防肺炎球菌疾病的经济学评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2400751. doi: 10.1080/21645515.2024.2400751. Epub 2024 Sep 15.
7
Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis.从德国社会角度分析PCV20预防儿童肺炎球菌疾病的成本效益
Infect Dis Ther. 2024 Jun;13(6):1333-1358. doi: 10.1007/s40121-024-00977-4. Epub 2024 May 11.
8
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions.20价肺炎球菌结合疫苗在美国患有基础疾病儿童中的成本效益
Infect Dis Ther. 2024 Apr;13(4):745-760. doi: 10.1007/s40121-024-00944-z. Epub 2024 Mar 16.
9
Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice.用重组卡介苗-肺炎球菌表面蛋白A-破伤风类毒素初免/加强免疫方案对新生小鼠进行免疫可引发强大免疫反应并保护其免受致死性肺炎球菌攻击
Vaccines (Basel). 2024 Jan 25;12(2):122. doi: 10.3390/vaccines12020122.
10
Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population.PCV20 预防加拿大儿童人群中肺炎球菌病的成本效益分析。
Hum Vaccin Immunother. 2023 Aug;19(2):2257426. doi: 10.1080/21645515.2023.2257426. Epub 2023 Sep 29.